# Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy

> **NCT02171390** · PHASE4 · COMPLETED · sponsor: **Gulhane School of Medicine** · enrollment: 130 (actual)

## Conditions studied

- Hypogonadotrophic Hypogonadism

## Interventions

- **DRUG:** Testosterone 250mg injection
- **DRUG:** Testosteron 50 mg transdermal gel

## Key facts

- **NCT ID:** NCT02171390
- **Lead sponsor:** Gulhane School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2012-06
- **Final completion:** —
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2014-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02171390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02171390, "Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02171390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*